Insider · CIK 0001873919

Aguilar-Cordova Estuardo

Reports to the SEC for 1 company · WABAN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001873919

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-21	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−10.6K sh	$12.02	−$127K	120,861
2025-02-21	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−10.6K sh	$12.02	−$127K	162,929
2025-02-10	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−31.3K sh	$8.61	−$270K	60,000
2024-12-27	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$8.85	−$443K	131,443
2024-12-27	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$8.85	−$443K	173,512
2024-12-26	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$9.01	−$451K	223,512
2024-12-26	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$9.01	−$451K	181,443
2024-12-24	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	+50K sh	$8.82	+$441K	273,512
2024-12-24	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$8.82	−$441K	231,443
2024-12-23	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$8.52	−$426K	281,443
2024-12-23	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−50K sh	$8.52	−$426K	323,512
2024-12-20	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−100K sh	$9.00	−$900K	331,443
2024-12-20	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−100K sh	$9.00	−$900K	373,512
2024-12-12	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−200K sh	$10.04	−$2.01M	431,443
2024-12-12	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−200K sh	$10.04	−$2.01M	473,512
2024-12-11	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−200K sh	$8.53	−$1.71M	673,512
2024-12-11	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−200K sh	$8.53	−$1.71M	631,443
2024-12-06	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−20K sh	$5.23	−$105K	91,335
2024-12-05	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−20K sh	$4.79	−$95.8K	111,335
2024-12-04	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−20K sh	$4.46	−$89.2K	131,335
2024-11-25	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−20K sh	$4.97	−$99.4K	151,335
2024-11-08	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$4.92	−$36.9K	831,443
2024-11-08	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$4.92	−$36.9K	873,512
2024-11-07	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.19	−$38.9K	838,943
2024-11-07	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.19	−$38.9K	881,012
2024-11-06	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.33	−$40K	888,512
2024-11-06	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.33	−$40K	846,443
2024-11-01	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.27	−$39.5K	896,012
2024-11-01	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.27	−$39.5K	853,943
2024-10-31	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.30	−$39.8K	903,512
2024-10-31	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,500 sh	$5.30	−$39.8K	861,443
2024-10-30	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−6,000 sh	$5.38	−$32.3K	911,012
2024-10-30	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−6,000 sh	$5.38	−$32.3K	868,943
2024-10-28	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−11.7K sh	$5.58	−$65.3K	888,532
2024-10-25	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−1,597 sh	$5.80	−$9,262.6	900,243
2024-10-24	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−16.4K sh	$5.53	−$90.8K	903,034
2024-10-24	CADLCandel Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−1,194 sh	$5.72	−$6,829.68	901,840
2024-10-15	CADLCandel Therapeutics, Inc.S Sale	10% Owner	SSale	−10.4K sh	$6.03	−$62.8K	919,461
2024-10-14	CADLCandel Therapeutics, Inc.S Sale	10% Owner	SSale	−15K sh	$6.02	−$90.3K	929,873
2024-10-11	CADLCandel Therapeutics, Inc.S Sale	10% Owner	SSale	−15K sh	$6.05	−$90.8K	944,873
2024-10-03	CADLCandel Therapeutics, Inc.S Sale	10% Owner	SSale	−1,800 sh	$6.85	−$12.3K	959,873
2024-10-02	CADLCandel Therapeutics, Inc.S Sale	10% Owner	SSale	−27K sh	$6.92	−$187K	961,673
2024-10-01	CADLCandel Therapeutics, Inc.S Sale	10% Owner	SSale	+6,214 sh	$7.01	+$43.6K	988,661
2023-06-28	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+14.2K sh	—	—	14,240
2022-10-13	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+14.2K sh	—	—	14,240
2022-05-06	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−46.3K sh	—	—	30,456
2022-05-06	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−12.2K sh	—	—	0
2022-05-06	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−76.7K sh	—	—	0
2022-05-06	CADLCandel Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+135K sh	$1.46	+$197K	1,151,106
2022-05-06	CADLCandel Therapeutics, Inc.F Tax Payment	10% Owner	FTax Payment	−54.1K sh	$3.65	−$197K	1,097,032

Recent filings

Accepted (ET)
Feb 254
Aguilar Laura K.0001873919-25-000002
SEC(opens sec.gov)
Feb 134
Aguilar Laura K.0001873919-25-000001
SEC(opens sec.gov)
Dec 304
Aguilar Laura K.0001873919-24-000011
SEC(opens sec.gov)
Dec 264
Aguilar Laura K.0001873919-24-000010
SEC(opens sec.gov)
Dec 134
Aguilar Laura K.0001873919-24-000009
SEC(opens sec.gov)
Dec 64
Aguilar Laura K.0001873919-24-000008
SEC(opens sec.gov)

Companies

Candel Therapeutics, Inc.10% OwnerCADL

Address

160 PAULSON RD.

WABAN, MA, 02468